• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首个诊断相关分组(DRG):终末期肾病项目对预付费系统的启示

The first DRG: lessons from the end stage renal disease program for the prospective payment system.

作者信息

Maxwell J H, Sapolsky H M

出版信息

Inquiry. 1987 Spring;24(1):57-67.

PMID:2951335
Abstract

When Medicare implemented the diagnosis related group (DRG) method of reimbursement for hospitals in 1983, it already had a decade of experience using a prospective payment arrangement for its end stage renal disease (ESRD) program. We reviewed this experience to determine the lessons for Medicare's reimbursement of hospital services. The use of a fixed price for renal dialysis encouraged the introduction of cost-saving techniques. Failure to reduce the price for dialysis in keeping with the cost reductions, however, prevented the government from realizing the full benefits of prospective payment. In addition, there were important changes in medical practice that had independent effects on the program. Similar influences are likely to shape the impact of prospective payment on hospital behavior.

摘要

1983年医疗保险计划实施针对医院的诊断相关分组(DRG)报销方法时,它在其终末期肾病(ESRD)项目中采用前瞻性支付安排已有十年经验。我们回顾了这段经历,以确定医疗保险对医院服务报销的经验教训。对肾透析采用固定价格鼓励了成本节约技术的引入。然而,未能根据成本降低情况降低透析价格,阻碍了政府充分实现前瞻性支付的益处。此外,医疗实践中发生了一些重要变化,这些变化对该项目产生了独立影响。类似的影响可能会塑造前瞻性支付对医院行为的作用。

相似文献

1
The first DRG: lessons from the end stage renal disease program for the prospective payment system.首个诊断相关分组(DRG):终末期肾病项目对预付费系统的启示
Inquiry. 1987 Spring;24(1):57-67.
2
Medicare program; end-stage renal disease prospective payment system. Final rule.医疗保险计划;终末期肾病前瞻性支付系统。最终规则。
Fed Regist. 2010 Aug 12;75(155):49029-214.
3
Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.医疗保险计划;终末期肾病计划;透析服务的前瞻性报销及特殊用途肾透析设施的批准——医疗保健财务管理局。最终规则。
Fed Regist. 1983 May 11;48(92):21254-91.
4
Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule.医疗保险计划;终末期肾病(ESRD)支付例外申请与器官获取成本——医疗保健财务管理局。最终规则。
Fed Regist. 1997 Aug 15;62(158):43657-74.
5
How dialysis is paid for: what the dialysis medical director should know, and why.透析费用的支付方式:透析医疗主任应了解的内容及原因。
Semin Dial. 2008 Jan-Feb;21(1):58-62. doi: 10.1111/j.1525-139X.2007.00393.x. Epub 2007 Dec 11.
6
Health policy report. Funding the End-Stage Renal-Disease Program.健康政策报告。为终末期肾病项目提供资金。
N Engl J Med. 1982 Feb 25;306(8):492-6. doi: 10.1056/NEJM198202253060828.
7
Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.拟议的“捆绑式”终末期肾病支付系统对一家小型透析机构的预期影响。
Nephrol News Issues. 2009 Jun;23(7):46, 48-52.
8
The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.医疗保险终末期肾病项目的成功:利润与私人市场的案例
N Engl J Med. 1981 Aug 20;305(8):434-8. doi: 10.1056/NEJM198108203050805.
9
Medicare programs; end-stage renal disease program; prospective reimbursement for dialysis services: Health Care Financing Administration. Proposed rule.医疗保险计划;终末期肾病计划;透析服务的预期报销:医疗保健财务管理局。拟议规则。
Fed Regist. 1982 Feb 12;47(30):6556-82.
10
Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.医疗保险计划;医院 inpatient 预期支付系统及 2007 财年费率的变更;2007 财年工资指数的职业构成调整;医疗保健基础设施改善计划;参与癌症相关医疗保健的合格医院贷款计划的选择标准及债务免除;以及在计算平均销售价格(ASP)时排除根据 B 部分门诊药品和生物制品的竞争性采购计划(CAP)进行的供应商采购。最终规则及有意见征求期的暂行最终规则。
Fed Regist. 2006 Aug 18;71(160):47869-8351.

引用本文的文献

1
A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs.一项针对透析中心效率的全国性研究:对多种透析产出生产中的市场竞争和机构特征的考察。
Health Serv Res. 2002 Jun;37(3):711-32. doi: 10.1111/1475-6773.00045.
2
Services utilization before and after the prospective payment system by patients with somatization disorder.躯体化障碍患者在预期支付系统实施前后的服务利用情况。
J Behav Health Serv Res. 1998 Feb;25(1):76-82. doi: 10.1007/BF02287502.
3
Factors associated with hospitalization in a sample of chronic hemodialysis patients.
慢性血液透析患者样本中与住院相关的因素。
Health Serv Res. 1991 Dec;26(5):671-99.